BI 2536;BI-2536
|
4-[[(7R)-8-環(huán)戊基-7-乙基-5,6,7,8-四氫-5-甲基-6-氧代-2-喋啶基]氨基]-3-甲氧基-N-(1-甲基-4-哌啶基)苯甲酰胺;4-[[(7R)-8-環(huán)戊基-7-乙基-5,6,7,8-四氫-5-甲基-6-氧代-2-戊啶基]氨基]-3-甲氧基-N-(1-甲基-4-哌啶基)-苯甲酰胺
|
755038-02-9
|
BI-6727
|
N-[反式-4-[4-(環(huán)丙基甲基)-1-哌嗪基]環(huán)己基]-4-[[(7R)-7-乙基-5,6,7,8-四氫-5-甲基-8-異丙基-6-氧代-2-蝶啶基]氨基]-3-甲氧基苯甲酰胺
|
755038-65-4
|
RVX-208
|
2-[3,5-二甲基-4-(2-羥基乙氧基)苯基]-5,7-二甲氧基喹唑啉-4(3H)-酮;2-(4-(2-羥基乙氧基)-3,5-二甲基苯基)-5,7-二甲氧基喹唑啉-4(3H)-酮;2-(4-(2-羥基乙氧基)-3,5-二甲基苯基)-5,7-二甲氧基-4(3H)-酮
|
1044870-39-4
|
BGB-283
|
BGB-TG-P1
|
1446090-77-2
|
HDM-201
|
NVP-HDM201
|
1448867-41-1
|
GDC-0981
|
(S)-1-[4-[[2-(2-氨基嘧啶-5-基)-7-甲基-4-(嗎啉-4-基)噻吩并[3,2-D]嘧啶-6-基]甲基]哌嗪-1-基]-2-羥基丙-1-酮
|
1032754-93-0
|
TAK-441
|
TAK-441
|
1186231-83-3
|
PKC-412
|
米哚妥林
|
120685-11-2
|
TAS-116
|
TAS-116
|
1260533-36-5
|
RG-120
|
艾伏尼布
|
1448347-49-6
|
AZD-3965
|
AZD3965
|
1448671-31-5
|
Pyridoclax
|
Pyridoclax
|
1651890-44-6
|
MS-275
|
恩替諾特
|
209783-80-2
|
Miriplatin
|
米鉑水合物
|
250159-48-9
|
H-1152
|
H-1152;H 1152;H1152
|
451462-58-1
|
Benzamide Riboside
|
苯甲酰胺核苷
|
138385-29-2
|
YM-155
|
4,9-二氫-1-(2-甲氧基乙基)-2-甲基-4,9-二氧代-3-(2-吡嗪甲基)-1H-萘并[2,3-D]咪唑溴化物
|
781661-94-7
|
CFI-400945 fumarate
|
CFI-400945
|
1338806-73-7
|
FK228
|
羅米地辛
|
128517-07-7
|
EPZ-5676,Pinometostat
|
EPZ 5676;9-[5-脫氧-5-[[順式-3-[2-[6-叔丁基-1H-苯并咪唑-2-基]乙基]環(huán)丁基](1-甲基乙基)氨基]-BETA-D-呋喃核糖基]-9H-嘌呤-6-胺
|
1380288-87-8
|
BMS-906024
|
BMS-906024
|
1401066-79-2
|
BYL-719
|
(2S)-N1-[4-甲基-5-[2-(2,2,2-三氟-1,1-二甲基乙基)-4-吡啶基]-2-噻唑基]-1,2-吡咯烷二甲酰胺;(2S)-N1-[4-甲基-5-[2-(2,2,2-三氟-1,1-二甲基乙基)-4-吡啶]-2-噻唑]-1,2-吡咯烷二羧酰胺
|
1217486-61-7
|
ARQ-197
|
(3R,4R)-3-(5,6-二氫-4H-吡咯并[3,2,1-IJ]喹啉-1-基)-4-(1H-吲哚-3-基)吡咯烷-2,5-二酮
|
905854-02-6
|
ARQ-087
|
德拉贊替尼
|
1234356-69-4
|
INCB 018424(Ruxolitinib Phosphate);INCB 018424 (phosphate);INCB018424 (phosphate)
|
(BETAR)-BETA-環(huán)戊基-4-(7H-吡咯并[2,3-D]嘧啶-4-基)-1H-吡唑-1-丙腈磷酸鹽;(BETAR)-BETA-環(huán)戊基-4-(7H-吡咯并[2,3-D]嘧啶-4-基)-1H-吡唑-1-丙腈磷酸;盧索替尼磷酸鹽;(3R)-3 -環(huán)戊基-3-4-[(7H吡咯并[2,3-D]嘧啶-4-基)-1H-吡唑基]丙腈磷酸;磷酸魯索利替尼;(BETAR)-BETA-環(huán)戊基-4-(7H-吡咯并[2,3-D]嘧啶-4-基)-1H-吡唑-1-丙腈磷酸鹽(魯索利替尼磷酸鹽);魯索利替尼磷酸鹽
|
1092939-17-7
|
GDC-0810
|
(E)-3-(4-((E)-2-(2-CHLORO-4-FLUOROPHENYL)-1-(1H-INDAZOL-5-YL)BUT-1-EN-1-YL)PHENYL)ACRYLIC ACID
|
1365888-06-7
|
PF-00299804
|
PF299804;(E)-N-(4-((3-CHLORO-4-FLUOROPHENYL)AMINO)-7-METHOXYQUINAZOLIN-6-YL)-4-(PIPERIDIN-1-YL)BUT-2-ENAMIDE;(2E)-N-[4-[(3-氯-4-氟苯基)氨基]-7-甲氧基-6-喹唑啉基]-4-(1-哌啶基)-2-丁烯酰胺;PF299804(EGFR抑制劑);PF299804;DACOMITINIB;達克替尼;PF299804,達克替尼;EGFR抑制劑;達克米替尼
|
1110813-31-4
|
FK866 (APO866);FK866 (APO866, Daporinad)
|
(2E)-N-[4-(1-苯甲?;?4-哌啶基)丁基]-3-(3-吡啶基)-2-丙烯酰胺;達珀利奈
|
658084-64-1
|
Panobinostat
|
帕比司他;2-丙烯酰胺, N-羥基-3-[4-[[[2-(2-甲基-1H-吲哚-3-基)乙基]氨基]甲基]苯基]-, (2E)-;帕比司他工藝及其雜質(zhì)
|
404950-80-7
|
MLN2238(iaxzomib);MLN2238(Ixazomib)
|
B-[(1R)-1-[[2-[(2,5-二氯苯甲?;?氨基]乙酰基]氨基]-3-甲基丁基]硼酸;埃沙佐米;艾沙佐米;IAXZOMIB阿西咗瞇;阿西佐米;阿西咗瞇
|
1072833-77-2
|
ABL-001
|
ABL-001
|
1492952-76-7
|
GDC-0994
|
GDC-0994
|
1453848-26-4
|
PF-06459988
|
化合物PF-06459988
|
1428774-45-1
|
Nifedipine
|
利心平 ;硝苯吡啶 ;硝苯啶 ;硝基地平 ;1,4-二氫-2,6-二甲基-4-(2-硝基苯基)-3,5-吡啶二羧酸二甲酯;心痛定;硝苯地平;硝苯地平(心痛定
|
21829-25-4
|
RS-102895hydrochloride
|
1'-[2-[4-(三氟甲基)苯基]乙基]-螺[4H-3,1-苯并惡嗪-4,4'-哌啶]-2(1H)-酮;RS 102895 鹽酸鹽
|
300815-41-2
|
EPZ-005687
|
EPZ005687
|
1396772-26-1
|
GKT-137831
|
2-(2-氯苯基)-4-[3-(二甲基氨基)苯基]-5-甲基-1H-吡唑并[4,3-C]吡啶-3,6(2H,5H)-二酮
|
1218942-37-0
|
ZSTK-474
|
2-(2-二氟甲基苯并咪唑-1-基)-4,6-二嗎啉基-1,3,5-三嗪;ZSTK474 BASE
|
475110-96-4
|
SW-044248
|
SW-044248
|
522650-83-5
|
KU-55933
|
2-嗎啉-4-基-6-噻蒽-1-基吡喃-4-酮
|
587871-26-9
|
ABT888_Freebase
|
2-[(2R)-2-甲基-2-吡咯烷基]-1H-苯并咪唑-7-甲酰胺;2-[(2R)-2-甲基-2-吡咯烷基]-1H-苯并咪唑-4-甲酰胺;VELIPARIBABT-888;API VELIPARIB;2-[(2R)-2-甲基-2-吡咯烷基]-1H-苯并咪唑-7-甲酰胺,奧拉帕尼中間體;(R)-2-(2-甲基-2-吡咯烷基)-1H-苯并咪唑-4-甲酰胺 (VELIPARIB);(S)-2-(2-(2-甲基)吡咯烷基)-1H-苯并咪唑-4-甲酰胺;ABT 888(維利帕尼)
|
912444-00-9
|
TAE-226
|
2-[[5-氯-2-[[2-甲氧基-4-(4-嗎啉基)苯基]氨基]-4-嘧啶基]氨基]-N-甲基苯甲酰胺
|
761437-28-9
|
MK-1775
|
2-烯丙基-1-(6-(2-羥基丙-2-基)吡啶-2-基)-6-(4-(4-甲基哌嗪-1-基)苯基氨基)-1H-吡唑并[3,4-D]嘧啶-3(2H)-酮
|
955365-80-7
|
GDC-0449
|
2-氯-N-[4-氯-3-(2-吡啶基)苯基]-4-(甲磺?;?苯甲酰胺;維莫地尼;2-氯-N-(4-氯-3-(吡啶-2-基)苯基)-4-(甲基磺酰基)苯甲酰胺;維莫德吉
|
879085-55-9
|
CP-690550
|
3-((3R,4R)-4-甲基-3-(甲基(7H-吡咯并[2,3-D]嘧啶-4-基)氨基)哌啶-1-基)-3-氧代丙腈;(3R,4R)-4-甲基-3-(甲基-7H-吡咯并[2,3-D]嘧啶-4-基氨基)-BETA-氧代-1-哌啶丙腈;3-((3R,4R)-4-甲基-3-(甲基(7H-吡咯并[2,3-D]嘧啶-4-基)氨基)哌啶-1-;1-哌啶丙腈, 4-甲基-3-(甲基-7H-吡咯并[2,3-D]嘧啶-4-基氨基)-Β-氧代-, (3R,4R)-;他索替尼;CP690550<3-<<3R,4R>-4-甲基
|
477600-75-2
|
MK-8033
|
3-(1-甲基-1H-吡唑-4-基)-5-氧代-N-(2-吡啶甲基)-5H-苯并[4,5]環(huán)己烯并[1,2-B]吡啶-7-甲磺酰胺
|
1001917-37-8
|
BGJ-398
|
3-(2,6-二氯-3,5-二甲氧基苯基)-1-[6-[[4-(4-乙基哌嗪-1-基)苯基]氨基]嘧啶-4-基]-1-甲基脲
|
872511-34-7
|
WDR5-0103
|
WDR5 0103
|
890190-22-4
|
AZD-2014
|
3-[2,4-雙((3S)-3-甲基嗎啉-4-基)吡啶并[5,6-E]嘧啶-7-基]-N-甲基苯甲酰胺
|
1009298-59-2
|
Pomalidomide
|
3-氨基-N-(2,6-二氧代-3-哌啶基)鄰苯二甲酰亞胺;泊馬度胺;4-氨基-2-(2,6-二氧哌啶-3-基)異吲哚啉-1,3-二酮;泊馬度胺-D4;4-氨基-2-(2,6-二氧代哌啶-3-基)異吲哚-1,3-二酮
|
19171-19-8
|
E-7080
|
4-[3-氯-4-(環(huán)丙基氨基羰基)氨基苯氧基]-7-甲氧基-6-喹啉甲酰胺;LENVATINIB;樂伐替尼;LENVATINIB E7080 樂伐替尼;樂伐替尼、E7080;4-[3-氯-4-(環(huán)丙基氨基羰基)氨基苯氧基]-7-甲氧基-6-喹啉甲酰胺 樂伐替尼;樂法替尼;樂伐替尼雜質(zhì)(A-D)
|
417716-92-8
|
GSK-2194069
|
1332331-08-4
|
1332331-08-4
|
ABT-737
|
4-[4-[(4'-氯[1,1'-聯(lián)苯]-2-基)甲基]-1-哌嗪基]-N-[[4-[[(1R)-3-(二甲基氨基)-1-[(苯硫基)甲基]丙基]氨基]-3-硝基苯基]磺?;鵠苯甲酰胺;4-[4-[(4'-氯-聯(lián)苯-2-基)甲基]哌嗪-1-基]-N-[[4-[[(1R)-3-(二甲胺基)-1-[(苯基硫基)甲基]丙基]氨基]-3-硝基苯基]磺?;鵠苯甲酰胺
|
852808-04-9
|
ABT-263
|
生根粉263;N-[2-[(1S,4R)-6-[[4-(環(huán)丁基氨基)-5-(三氟甲基)-2-嘧啶]氨基]-1,2,3,4-四氫萘-1,4-脒-9-基]-2-氧代乙基]乙酰胺;生根粉263(不確定)
|
923564-51-6
|
TKI-258
|
4-氨基-5-氟-3-[5-(4-甲基哌嗪-1-基)-1H-苯并咪唑-2-基]喹啉-2(1H)-酮;TKI258; CHIR-258;多韋替尼堿
|
405169-16-6
|
Risperidone
|
利培酮;3-[2-[4-(6-氟-1,2-苯并異噁唑-3-基)-1-哌啶]乙基]-6,7,8,9-四氫-2-甲基-4H-吡啶并[1,2-a]嘧啶-4-酮;3-[2-[4-(6-氟-1,2-苯并異噁唑-3-基)-1-哌啶基]乙基]-6,7,8,9-四氫-2-甲基-4H-吡啶并[1,2-α]嘧啶-4-酮;瑞司哌酮;瑞斯哌東;利哌利酮,利司環(huán)酮,利司培酮;3-[2-[4-(6-氟-1,2-苯并異噁唑-3-基)哌啶-1-基]乙基]-6,7,8,9-四氫-2-甲基-4H-吡啶并[1,2-Α]嘧啶-4-酮;利哌利酮
|
106266-06-2
|
Formestane
|
4-羥基-睪酮 ;福美斯坦 ;福美坦 ;福美司坦;4-羥基雄甾烷-4-烯-3,17-二酮;4-雄烯-4-醇-3,17-二酮;芳香化酶(抗原);芳香化酶/(細胞色素P450)(P450)(抗體)
|
566-48-3
|
Temozolomide
|
3,4-二氫-3-甲基-4-氧代咪唑并[5,1-d]-1,2,3,5-四嗪-8-甲酰胺;4-甲基-5-氧代-2,3,4,6,8-五氮雜雙環(huán)[4.3.0]壬-2,7,9-三烯-9-甲酰胺;替莫唑胺;3,4-二氫-3-甲基-4-氧咪唑并[5,1-D]-1,2,3,5-四唑-8-羧酰胺;替莫唑銨;替莫唑胺98%;替莫唑胺(蒂清);TEMODAR TEMOZOLOMIDE
|
85622-93-1
|
INK-128
|
3-(2-氨基-5-苯并惡唑基)-1-(1-甲基乙基)-1H-吡唑并[3,4-D]嘧啶-4-胺
|
1224844-38-5
|
AZD-1480
|
5-氯-N2-[(1S)-1-(5-氟-2-嘧啶基)乙基]-N4-(5-甲基-1H-吡唑-3-基)-2,4-嘧啶二胺
|
935666-88-9
|
BIIB-024;MLN 2480;MLN2480 (BIIB-024)
|
6-氨基-5-氯-N-[(1R)-1-[5-[[[5-氯-4-(三氟甲基)-2-吡啶基]氨基]羰基]-2-噻唑基]乙基]-4-嘧啶甲酰胺
|
1096708-71-2
|
GSK-2606414
|
GSK2606414;7-甲基-5-[1-[[3-(三氟甲基)苯基]乙酰基]-2,3-二氫-1H-吲哚-5-基]-7H-吡咯并[2,3-D]嘧啶-4-胺
|
1337531-36-8
|
CCT-251921
|
CCT251921
|
1607837-31-9
|
CH-5424802
|
9-乙基-6,11-二氫-6,6-二甲基-8-[4-(4-嗎啉基)-1-哌啶基]-11-氧代-5H-苯并[B]咔唑-3-甲腈;9-ETHYL-6,6-DIMETHYL-8-(4-MORPHOLINOPIPERIDIN-1-YL)-11-OXO-6,11-DIHYDRO-5H-BENZO[B]CARBAZOLE-3-CARBONITRILE;艾樂替尼ALECTINIB (CH5424802);艾樂替尼;9-乙基-6,6-二甲基-8-(4-嗎啉哌啶-1-基)-11-氧代-6,11-二氫-5H-苯并[B]咔唑-
|
1256580-46-7
|
A-1210477
|
A-1210477
|
1668553-26-1
|
ABC294640
|
3-(4-氯苯基)-N-(4-吡啶基甲基)金剛烷-1-甲酰胺
|
915385-81-8
|
ABT-199;ABT199,GDC0199;GDC 0199;GDC0199;GDC-0199;4-[4-[[2-(4-Chlorophenyl)-4,4-dimethyl-1-cyclohexen-1-yl]methyl]-1-piperazinyl]-N-[[3-nitro-4-[[(tetrahydro-2H-pyran-4-yl)methyl]amino]phenyl]sulfonyl]-2-(1H-pyrrolo[2,3-b]pyridin-5-yloxy)-benzamide;Benzamide, 4-[4-[[2-(4-chlorophenyl)-4,4-dimethyl-1-cyclohexen-1-yl]methyl]-1-piperazinyl]-N-[[3-nitro-4-[[(tetrahydro-2H-pyran-4-yl)methyl]amino]phenyl]sulfonyl]-2-(1H-pyrrolo[2,3-b]pyridin-5-yloxy)-;4-[4-[[2-(4-Chlorophenyl)-4,4-dimethyl-1-cyclohexen-1-yl]methyl]-1-piperazinyl]-N-[[3-nitro-4-[[(tetrahydro-2H-pyran-4-yl)methyl]amino]phenyl]sulfonyl]
|
ABT-199
|
1257044-40-8
|
Doxorubicin HCI
|
(8S-cis)-10-[(3-氨基-2,3,6-三去氧-a-L-來蘇己吡喃基)-氧]-7,8,9,10-四氫-6,8,11-三羥基-8-羥基乙?;?1-甲氧基-5,12-并四苯二酮鹽酸鹽;鹽酸多柔比星;14-羥正定霉素 ;阿得里亞霉素 ;(8S-cis)-10-((3-氨基-2,3,6-三去氧-a-L-來蘇己吡喃基)-氧)-7,8,9,10-四氫-6,8,11-三羥基-8-羥基乙?;?1-甲氧基-5,12-并四苯二酮鹽酸鹽;阿霉素鹽酸鹽;亞德里亞霉素鹽酸鹽;鹽酸阿霉素
|
25316-40-9
|
AEE-788
|
6-[4-[(4-乙基-1-哌嗪)甲基]苯基]-N-[(1R)-1-苯基乙基]-7H-吡咯并[2,3-D]嘧啶-4-胺;AEE 788AEE-788
|
497839-62-0
|
AG-120;AG-120 racemic;AG-120 Ivosidenib
|
1-(4-氰基-2-吡啶基)-5-氧代-L-脯氨酰-2-(2-氯苯基)-N-(3,3-二氟環(huán)丁基)-N2-(5-氟-3-吡啶基)甘氨酰胺
|
1448346-63-1
|
AGI-6780
|
N-環(huán)丙基-4-(3-噻吩基)-3-[[[[3-(三氟甲基)苯基]氨基]羰基]氨基]-苯磺酰胺
|
1432660-47-3
|
AZD 3463;AZD3463;AZD-3463
|
N-[4-(4-氨基-1-哌啶基)-2-甲氧基苯基]-5-氯-4-(1H-吲哚-3-基)-2-嘧啶胺
|
1356962-20-3
|
ALR-3456;ALR-3456 , MK-0731
|
(2S)-4-(2,5-二氟苯基)-N-[(3R,4S)-3-氟-1-甲基-4-哌啶基]-2,5-二氫-2-羥基甲基-N-甲基-2-苯基-1H-吡咯-1-羧胺
|
845256-65-7
|
Ap 23573;Ap23573;Ap-23573;Mk-8669
|
42-(二甲基亞膦酰)雷帕霉素
|
572924-54-0
|
AP-26113
|
5-氯-N2-[4-[4-(二甲基氨基)-1-哌啶基]-2-甲氧基苯基]-N4-[2-(二甲基亞膦酰)苯基]-2,4-嘧啶二胺
|
1197953-54-0
|
ARRY 142886;AZD 6244
|
5-[(4-溴-2-氯苯基)氨基]-4-氟-N-(2-羥基乙氧基)-1-甲基-1H-苯并咪唑-6-甲酰胺;5-[(4-溴-2-氯苯基)氨基]-4-氟-N-(2-羥基乙氧基)-1-甲基-1H-苯并[D]咪唑-6-甲酰胺;AZD6244; ARRY142886;3-氧雜-9-氮雜螺[5.5]十一烷鹽酸鹽;司美替尼-AZD6244;司美替尼;司美替尼(系統(tǒng)里沒有)
|
606143-52-6
|
ARRY-380
|
6-[5-[[[2-(甲磺?;?乙基]氨基]
|
937263-43-9
|
ARRY-424704, ARRY-704;AZD8330
|
2-(2-氟-4-碘苯氨基)-N-(2-羥基乙氧基)-1,5-二甲基-6-氧代-1,6-二氫吡啶-3-甲酰胺;AZD-83302-(2-氟-4-碘苯氨基)-N-(2-羥基乙氧基)-1,5-二甲基-6-氧代-1,6-二氫吡啶-3-甲酰胺
|
869357-68-6
|
ASP-3026
|
N2-[2-甲氧基-4-[4-(4-甲基-1-哌嗪基)-1-哌啶基]苯基]-N4-[2-[(1-甲基乙基)磺酰基]苯基]-1,3,5-三嗪-2,4-二胺
|
1097917-15-1
|
ASP-2215;Gilteritinib
|
吉列替尼
|
1254053-43-4
|
Rapamycin
|
雷帕霉素;雷帕霉素,99%;瑞帕霉素;西羅莫司(雷帕霉素);西羅莫司口服液;雷帕霉素/西羅莫司;雷帕酶素;西羅莫司
|
53123-88-9
|
AZD 1208;AZD1208;AZD-1208;
|
(5Z)-5-[[2-[(3R)-3-氨基-1-哌啶基][1,1'-聯(lián)苯]-3-基]亞甲基]-2,4-噻唑烷二酮
|
1204144-28-4
|
AZD-0156
|
AZD0156
|
1821428-35-6
|
AZD-0530
|
塞卡替尼
|
379231-04-6
|
AZD3514
|
AZD3514
|
1240299-33-5
|
AZD-4547
|
AZD-4547
|
1035270-39-3
|
AZD-5363
|
4-氨基-N-[(1S)-1-(4-氯苯基)-3-羥基丙基]-1-(7H-吡咯并[2,3-D]嘧啶-4-基)-4-哌啶甲酰胺
|
1143532-39-1
|
AZD-5582
|
AZD 5582
|
1258392-53-8
|
AZD6738;AZD-6738
|
AZD6738
|
1352226-88-0
|
AZD-8055
|
[5-[2,4-二((3S)-3-甲基嗎啉-4-基)吡啶并[2,3-D]嘧啶-7-基]-2-甲氧基苯基]甲醇;CCG 168
|
1009298-09-2
|
AZD8186;AZD 8186
|
8-[(1R)-1-[(3,5-二氟苯基)氨基]乙基]-N,N-二甲基-2-(4-嗎啉基)-4-氧代-4H-1-苯并吡喃-6-甲酰胺
|
1627494-13-6
|
b-AP15;NSC-687852
|
b-AP15
|
1009817-63-3
|
BAY 87-2243
|
BAY87-2243
|
1227158-85-1
|
BAY1125976; BAY 1125976; BAY-1125976.
|
CS-2913
|
1402608-02-9
|
BAY1143572; BAY 1143572; BAY-1143572.
|
ATUVECICLIB RACEMATE (BAY-1143572 RACEMATE)
|
1414943-88-6
|
INC280;INCB028060;CapMatinib (INCB28060);CapMatinib
|
2-氟-N-甲基-4-[7-[(喹啉-6-基)甲基]咪唑并[1,2-B]-[1,2,4]三嗪-2-基]苯甲酰胺;苯扎米特;INCB28060(苯扎米特)
|
1029712-80-8
|
BMS-863233
|
XL413 (BMS-863233)
|
1169562-71-3
|
EMD-1214063
|
3-(1-(3-(5-((1-METHYLPIPERIDIN-4-YL)METHOXY)PYRIMIDIN-2-YL)BENZYL)-1,6-DIHYDRO-6-OXOPYRIDAZIN-3-YL)B;3-[1,6-二氫-1-[[3-[5-[(1-甲基-4-哌啶基)甲氧基]-2-嘧啶基]苯基]甲基]-6-氧代-3-噠嗪基]苯腈
|
1100598-32-0
|
BGB 102;BGB102;BGB-102;JNJ 26483327;JNJ26483327;JNJ-26483327
|
17-溴-1,8,9,10,11,12,13,14-八氫-20-甲氧基-13-甲基-4,6-乙烯橋嘧啶并[4,5-B][6,1,12]苯并氧雜二氮雜環(huán)十五碳七烯
|
807640-87-5
|
BGT-226 Free base
|
BGT226
|
915020-55-2
|